Christine Roy,Elisabeth Souhami,Nacima Demil,Jenny Ye
申请号：
US15646760
公开号：
US20180092965A1
申请日:
2017.07.11
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A pharmaceutical combination for use in glycemic control in a type 2 diabetes mellitus patient, said combination comprising (i) lixisenatide or/and a pharmaceutically acceptable salt thereof, (ii) insulin glargine or/and a pharmaceutically acceptable salt thereof, and (iii) optionally metformin or/and a pharmaceutically acceptable salt thereof.
